Ana Zabalza

Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

Thaís Armangué, Marianna Spatola, Alexandru Vlagea et al. · The Lancet Neurology · 2018 · 648 citations · Full text

Life Sciences, Immunology, Neurology +16

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

Carmen Tur, Pere Carbonell‐Mirabent, Álvaro Cobo‐Calvo et al. · JAMA Neurology · 2022 · 275 citations · Full text

Life Sciences, Neurology, Clinical Neuroscience +15

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Steve Simpson, Edward De Brouwer, Tomáš Kalinčík et al. · Cronfa (Swansea University) · 2021 · 157 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response

Ana Zabalza, Simón Cárdenas‐Robledo, Paula Tagliani et al. · European Journal of Neurology · 2020 · 138 citations

Veterinary Medicine, Clinical Sciences, Infectious Diseases +16

Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome

Mar Tintoré, Álvaro Cobo‐Calvo, Pere Carbonell et al. · Neurology · 2021 · 81 citations

Medicine, Internal Medicine, Neurology +17